New coronoviral infection (COVID-19) combined with tuberculosis in patients at late stages of HIV infection with immunodeficiency
https://doi.org/10.22328/2077-9828-2021-13-1-80-87
Abstract
The study materials of 23 patients with COVID-19, combined with newly diagnosed tuberculosis at the late stages of HIV infection with an average CD4+ cells count not exceeding 30 cells/μl of blood and in the absence of antiretroviral therapy (the main group) and 23 patients with no COVID-19 (the comparison group) and the similar parameters are presented. The presence or absence of COVID-19 is characterized by social maladjustment, drug addiction, concomitant viral hepatitis B or C and COPD, generalized tuberculosis with extrapulmonary damage of various organs and the development of other opportunistic pulmonary infections, similar clinical and radiological manifestations, which can only be differentiated by microbiological and molecular genetic research methods. To prevent exogenous infection of the healthy population with COVID-19, it is imperative to organize an active regular examination of all patients with tuberculosis and HIV infection for COVID-19, especially at the later stages, in the TB care office for HIV-infected people at TB dispensaries.
About the Authors
A. V. MishinaRussian Federation
Moscow
V. Yu. Mishin
Russian Federation
Moscow
A. E. Ergeshov
Russian Federation
Moscow
A. L. Sobkin
Russian Federation
Moscow
N. V. Sergeeva
Russian Federation
Moscow
S. V. Pilipenko
Russian Federation
Moscow
V. V. Romanov
Russian Federation
Moscow
References
1. Undiagnosed pneumonia — China (HU): RFI. Archive Number: 20191230.6864153 https://promedmail.org/promed-post/?id=6864153 (Available 2019-12-30 23:59:00).
2. Undiagnosed pneumonia — China (HU) (07): official confirmation of novel coronavirus. Archive Number: 20200108.6878869, https://promedmail.org/promedpost/?id=20200108.6878869 (Available 2020-01-08 23:19:25).
3. Blanco J., Ambrosioni J., Garcia F., Martínez E., Soriano A., Mallolas J., Miro J.M. COVID-19 in HIV Investigators. COVID-19 in patients with HIV: clinical case series // Lancet HIV. 2020. Apr. 15. pii: S2352-3018(20)30111-9.
4. Docherty A.B., Harrison E.M., Green C.A., Hardwick H.E., Pius R., Norman L., Holden K.A., Read M., Dondelinger F., Carson G., Merson L., Lee J., Plotkin D., Sigfrid L., Halpin S., Jackson C., Gamble C., Horby P.W., Nguyen-Van-Tam J.S., Dunning J., Openshaw P.J.M., Baillie J.K., Semple M.G. Features of 16,749 hospitalised UK patients with COVID-19 using the ISARIC WHO clinical characterization protocol // medRxiv preprint. https://doi. https://doi.org/10.1101/2020.04.23.20076042.
5. Gervasoni C., Meraviglia P., Riva A., Giacomelli A., Oreni L., Minisci D., Atzori C., Ridolfo A., Cattaneo D. Clinical features and outcomes of HIV patients with coronavirus disease 2019 // Clin. Infect. Dis. 2020. May 14. pii: ciaa579. https://doi.10.1093/cid/ciaa579. [Epub ahead of print]
6. Guo W., Ming F., Dong Yu., Zhang Q., Zhang X., Pingzheng M., Yong F., Liang K. A Survey for COVID-19 among HIV/AIDS Patients in Two Districts of Wuhan // The Lancet. D-20–02926. China-Manuscript. Draft-Manuscript. https://doi:10.2139/ssrn.3550029.
7. Härter G., Spinner C.D., Roider J., Bickel M., Krznaric I., Grunwald S., Schabaz F., Gillor D., Postel N., Mueller M.C., Müller M., Römer K., Schewe K., Hoffmann C. COVID-19 in people living with human immunodeficiency virus: a case series of 33 patients // Infection. 2020 May 11. https://doi.10.1007/s15010-020-01438-z. [Epub ahead of print]
8. Karmen-Tuohy S., Carlucci P.M., Zacharioudakis I.M., Zervou F.N., Rebick G., Klein E., Reich J., Jones S., Rahimian J. Outcomes among HIVpositive patients hospitalized with COVID-19 // medRxiv. https://www.medrxiv.org/content/10.1101/2020.05.07.20094797v1. [This preprint report has not been peer-reviewed]
9. Wu Q., Chen T., Zhang H. Recovery from COVID-19 in two patients with coexisted HIV infection // J. Med. Virol. 2020 May 13. https://doi.10.1002/jmv.26006.
10. Resources and activities of anti-tuberculosis institutions of the Russian Federation in 2017–2018. (statistical materials). Moscow: Рublishing house TSNIIOIZ, 2019, 101 p. (In Russ.).
11. Temporary methodical recommendations of the Ministry of Health of the Russian Federation. Prevention, diagnosis, and management of the novel coronavirus infection (COVID-19). Version 9 (26.10.2020), 235 p. (In Russ.).
12. Temporary methodical recommendations on TB management in the conditions of the novel coronavirus infection (COVID-19) pandemic. The All-Russian Public Organization «Russian Society of Phthisiatricians», 2020, 46 p. (In Russ.).
13. Federal clinical recommendations on diagnosis and management of TB in HIV-infected patients. Moscow–Tver: Рublishing house Triada, 2014, 56 p. (In Russ.).
14. Communityacquired pneumonia MKB 10: J13-J18. Clinical recommendations of the Russian Respiratory Society (RRS) and the Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy (IACMAC), 2018, 88 p. (In Russ.) http://topuch.ru/vnebolenichnaya-pnevmoniya-mkb-10-j13-j18/index.html.
15. HIV infection and AIDS. Clinical recommendations. Ed. by V.V.Pokrovsky, 4th revised and enlarged edition. Moscow: Рublishing house GEOTAR-Media, 2019, 156 p. (In Russ.).
16. HIV infection in adults. Clinical recommendations endorsed by the Ministry of Health of the Russian Federation. The National Association of Specialists in Prevention, Diagnosis and Management of HIV infection, 2020, 530 p. (In Russ.). https://lunaids.org/wp-content/uploads/2020/01/Klinicheskie-rekomendaczii-VICH-infekcziya-u-vzroslyh-2019-god.pdf.
Review
For citations:
Mishina A.V., Mishin V.Yu., Ergeshov A.E., Sobkin A.L., Sergeeva N.V., Pilipenko S.V., Romanov V.V. New coronoviral infection (COVID-19) combined with tuberculosis in patients at late stages of HIV infection with immunodeficiency. HIV Infection and Immunosuppressive Disorders. 2021;13(1):80-87. (In Russ.) https://doi.org/10.22328/2077-9828-2021-13-1-80-87